Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/1995
06/27/1995US5428020 Cysteine (NPYS)-containing peptides and use thereof for inhibiting platelet aggregation
06/27/1995US5428019 Bombesin analogs
06/27/1995US5428018 Phenylalanine analogs of bombesin
06/27/1995US5428009 Lipopeptide derivatives
06/27/1995US5427960 Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
06/27/1995US5427958 Detecting presence of autoantibodies in biological fluids; forming peptide complexes; in vitro; diagnosing lupus, autoimmune diseases
06/27/1995US5427792 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
06/22/1995WO1995016702A1 Peptide inhibitors of cxc intercrine molecules
06/22/1995WO1995016462A1 Method for antigen-specific immunoregulation by t-cell alpha chain
06/22/1995CA2179018A1 Method for antigen-specific immunoregulation by t-cell alpha chain
06/22/1995CA2178927A1 Peptide inhibitors of cxc intercrine molecules
06/21/1995EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
06/21/1995EP0658115A1 Peptide medicaments for treating disease
06/21/1995EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
06/20/1995US5426038 Process for production of an antibiotic compound with Zalerion arboricola
06/20/1995US5425936 Useful for therapeutic, prophylactic and diagnostic purposes
06/20/1995CA1335967C Characterization and detection of sequences associated with insulin-dependent diabetes
06/15/1995WO1995016209A1 Process for the production of combinatorial compound libraries
06/15/1995WO1995016202A1 Labelling of nucleic acid analogue-peptide chimerae
06/15/1995WO1995015973A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995WO1995015767A1 Long-acting injection suspensions and a process for their preparation
06/15/1995WO1995015766A1 Antiviral peptides
06/15/1995WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995WO1995013297A3 Improved immunogenic compositions against human gastrin 17
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
06/15/1995CA2175078A1 Process for the production of combinatorial compound libraries
06/14/1995EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof
06/14/1995EP0657467A1 Antitumor antibiotics
06/14/1995EP0657171A1 Endoparasiticide drugs on a basis of open chain octadepsipeptides
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656952A1 Cationic peptides and method for production
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
06/14/1995EP0656945A1 Stress protein epitopes
06/14/1995EP0656907A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
06/14/1995EP0656904A1 Peptide inhibitors of selectin binding
06/14/1995EP0656903A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase
06/14/1995EP0656784A1 Parathyroid hormone fragments and analogs
06/14/1995DE4342846A1 Peptide(s) or their derivs. binding to tumour-necrosis factor alpha
06/13/1995US5424398 A polypeptide supporting with a solid as antibody inhibitor
06/13/1995US5424396 Containing three to six amino acids
06/13/1995US5424186 Very large scale immobilized polymer synthesis
06/13/1995CA1335879C Receptor membranes
06/08/1995WO1995015382A1 Binding structures directed against the ca55.1 antigen
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015336A1 Double-chain hemoregulatory peptides
06/08/1995WO1995015335A2 Pretargeting methods and compounds
06/08/1995WO1995011912A3 Biopolymer synthesis utilizing surface activated, organic polymers
06/08/1995CA2177136A1 Pretargeting methods and compounds
06/08/1995CA2174972A1 Binding structures directed against the ca55.1 antigen
06/07/1995EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
06/07/1995EP0656012A1 T cell epitopes of ryegrass pollen allergen
06/07/1995EP0656008A1 Thrombin receptor antagonists
06/07/1995EP0598034A4 Production of peptide amides.
06/06/1995US5422341 Motilin-like polypeptides with gastrointestinal motor stimulating activity
06/06/1995US5422110 Enhanced immunogenicity using leukotoxin chimeras
06/01/1995WO1995014714A1 Novel integrin-binding peptides
06/01/1995WO1995014706A1 Pna-dna-pna chimeric macromolecules
06/01/1995CA2177070A1 Novel integrin-binding peptides
05/1995
05/31/1995EP0655462A1 Linear adhesion inhibitors
05/31/1995EP0655069A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
05/31/1995EP0329778B1 Molecular decoyants and methods of use thereof
05/30/1995US5420246 Having a predetermined amount of each peptide
05/30/1995US5420245 Tetrapeptide-based inhibitors of farnesyl transferase
05/30/1995US5420109 Cytokine restraining agents
05/30/1995CA1335722C Polyethylene glycol derivatives, modified peptides and production thereof
05/24/1995CA2135587A1 Antitumor antibiotics
05/23/1995CA1335662C Peptide derivatives for the treatment and prevention of asthma and the like
05/18/1995WO1995013384A1 Tomato xyloglucan endo-transglycosylase
05/18/1995WO1995013372A1 Brain-derived membrane-associated crf binding proteins
05/18/1995WO1995013297A2 Improved immunogenic compositions against human gastrin 17
05/18/1995WO1995013086A1 Cytokine restraining agents
05/18/1995WO1995013085A1 Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
05/18/1995WO1995013083A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
05/18/1995CA2176375A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
05/18/1995CA2176133A1 Tomato xyloglucan endo-transglycosylase
05/18/1995CA2175373A1 Brain-derived membrane-associated crf binding proteins
05/17/1995EP0652900A1 Thrombin inhibitors
05/17/1995EP0652898A1 Methods for detecting pre-clinical iddm
05/17/1995EP0652897A1 Peptide inhibitors of selectin binding
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652798A1 Sorbent families
05/17/1995EP0652765A1 Des-tyr dynorphin analogues
05/17/1995EP0652764A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens
05/17/1995EP0486520B1 Dynorphin analogs specific for kappa opioid receptors
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416191 Bradykinin antagonists
05/16/1995US5416021 Fibronectin binding protein-encoding DNA
05/16/1995US5416013 DNA sequences of polypeptides from genetic engineering
05/16/1995US5415995 Diagnostic peptides of human papilloma virus
05/16/1995CA1335622C Bradykinin analogs containing a non-peptide bond
05/16/1995CA1335568C Cosmetic and skin treatment compositions
05/11/1995WO1995012613A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds
05/11/1995WO1995012309A1 NUCLEIC ACIDS ENCODING [His?5, Trp7, Tyr8¿]-GnRH PREPROHORMONE AND [Ser8]-GnRH PREPROHORMONE AND THEIR USES
05/11/1995CA2552499A1 Immunodominant human t-cell epitopes of hepatitis c virus
05/11/1995CA2173845A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds
05/11/1995CA2135330A1 Live vaccine vectors based on mycoplasma gallisepticum and nucleic acid probes therefrom
05/10/1995EP0670729A4 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs.
05/10/1995EP0652225A1 Use of D-Gluocopyranosiduronic acids and their derivatives for incorporation into pharmacologically active peptides and their salts